Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Carter

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
European Journal of Immunology|April 1, 1989
The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatmentK C Carter, G Gallagher, A J Baillie, et al.
Methods (San Diego, Calif.)|January 13, 2006
Translation of an experimental oral vaccine formulation into a commercial productK C Carter, V A Ferro, J Alexander, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovaniK C Carter, A B Mullen, S Sundar, et al.
The Journal of Pharmacy and Pharmacology|March 3, 1999
Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasisD Williams, A B Mullen, A J Baillie, et al.
Journal of Biomedical Nanotechnology|August 3, 2012
Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasisJ L Italia, M N V Ravi Kumar, K C Carter
The Journal of Pharmacy and Pharmacology|May 1, 1988
The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependentK C Carter, A J Baillie, J Alexander, et al.
Experimental Parasitology|May 1, 1989
Visceral leishmaniasis: resistance to reinfection in the liver following chemotherapy in the BALB/c mouseK C Carter, J Alexander, A J Baillie, et al.
Nucleic Acids Research|March 1, 1996
Molecular cloning and functional analysis of a human cDNA encoding an Escherichia coli AlkB homolog, a protein involved in DNA alkylation damage repairY F Wei, K C Carter, R P Wang, et al.
European Journal of Immunology|November 9, 2000
Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasisJ Alexander, K C Carter, N Al-Fasi, et al.
The Journal of Cell Biology|July 1, 1994
Dynamic changes in the higher-level chromatin organization of specific sequences revealed by in situ hybridization to nuclear halosM G Gerdes, K C Carter, P T Moen, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
European Journal of Immunology|April 1, 1989
The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatmentK C Carter, G Gallagher, A J Baillie, et al.
Methods (San Diego, Calif.)|January 13, 2006
Translation of an experimental oral vaccine formulation into a commercial productK C Carter, V A Ferro, J Alexander, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovaniK C Carter, A B Mullen, S Sundar, et al.
The Journal of Pharmacy and Pharmacology|March 3, 1999
Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasisD Williams, A B Mullen, A J Baillie, et al.
Journal of Biomedical Nanotechnology|August 3, 2012
Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasisJ L Italia, M N V Ravi Kumar, K C Carter
The Journal of Pharmacy and Pharmacology|May 1, 1988
The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependentK C Carter, A J Baillie, J Alexander, et al.
Experimental Parasitology|May 1, 1989
Visceral leishmaniasis: resistance to reinfection in the liver following chemotherapy in the BALB/c mouseK C Carter, J Alexander, A J Baillie, et al.
Nucleic Acids Research|March 1, 1996
Molecular cloning and functional analysis of a human cDNA encoding an Escherichia coli AlkB homolog, a protein involved in DNA alkylation damage repairY F Wei, K C Carter, R P Wang, et al.
European Journal of Immunology|November 9, 2000
Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasisJ Alexander, K C Carter, N Al-Fasi, et al.
The Journal of Cell Biology|July 1, 1994
Dynamic changes in the higher-level chromatin organization of specific sequences revealed by in situ hybridization to nuclear halosM G Gerdes, K C Carter, P T Moen, et al.
Pageof 11